- Language
-
Englisch
- Bibliographic citation
-
Journal: NBER Reporter ; Year: 2018 ; Issue: 4 ; Pages: 12-15 ; Cambridge, MA: National Bureau of Economic Research (NBER)
- Classification
-
Wirtschaft
- Event
-
Geistige Schöpfung
- (who)
-
Jin, Ginger Zhe
- Event
-
Veröffentlichung
- (who)
-
National Bureau of Economic Research (NBER)
- (where)
-
Cambridge, MA
- (when)
-
2018
- Handle
- Last update
-
10.03.2025, 11:41 AM CET
Data provider
This object is provided by:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.
Object type
- Artikel
Associated
- Jin, Ginger Zhe
- National Bureau of Economic Research (NBER)
Time of origin
- 2018
Other Objects (12)
Pricing and Reimbursement of Prescription Drugs in German Social Health Insurance
Out-of-Pocket Prescription Drug Expenditures and Public Prescription Drug Programs
“Give Me Happiness” or “Take Away My Pain”: Explaining consumer responses to prescription drug advertising
The Mitigating Role of Prescription Drug Monitoring Programs in the Abuse of Prescription Drugs
Products Liability and Prescription Drug Prices in Canada and the United States
Germany's Struggle with Prices for Patent-protected Drugs
Managed Care: Prescription for Failure? Lessons from Switzerland
Constant-Quality House Price Indexes for Switzerland
Predictors of negotiated prices for new drugs in Germany
Prescription Drug Monitoring Programs and Neonatal Outcomes
Factors influencing general practitioners in the prescription of homeopathic medicines
Gender-Based Differences in Drug Prescription: Relation to Adverse Drug Reactions
Pricing and Reimbursement of Prescription Drugs in German Social Health Insurance
Out-of-Pocket Prescription Drug Expenditures and Public Prescription Drug Programs
“Give Me Happiness” or “Take Away My Pain”: Explaining consumer responses to prescription drug advertising
The Mitigating Role of Prescription Drug Monitoring Programs in the Abuse of Prescription Drugs
Products Liability and Prescription Drug Prices in Canada and the United States
Germany's Struggle with Prices for Patent-protected Drugs
Managed Care: Prescription for Failure? Lessons from Switzerland
Constant-Quality House Price Indexes for Switzerland
Predictors of negotiated prices for new drugs in Germany
Prescription Drug Monitoring Programs and Neonatal Outcomes
Factors influencing general practitioners in the prescription of homeopathic medicines
Gender-Based Differences in Drug Prescription: Relation to Adverse Drug Reactions
Pricing and Reimbursement of Prescription Drugs in German Social Health Insurance
Out-of-Pocket Prescription Drug Expenditures and Public Prescription Drug Programs
“Give Me Happiness” or “Take Away My Pain”: Explaining consumer responses to prescription drug advertising
The Mitigating Role of Prescription Drug Monitoring Programs in the Abuse of Prescription Drugs
Products Liability and Prescription Drug Prices in Canada and the United States
Germany's Struggle with Prices for Patent-protected Drugs
Managed Care: Prescription for Failure? Lessons from Switzerland
Constant-Quality House Price Indexes for Switzerland
Predictors of negotiated prices for new drugs in Germany
Prescription Drug Monitoring Programs and Neonatal Outcomes
Factors influencing general practitioners in the prescription of homeopathic medicines